Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery
- Rubio-Herrera, M.A.
- Mera-Carreiro, S.
- Sánchez-Pernaute, A.
- Ramos-Levi, A.M.
Aldizkaria:
Biomedicines
ISSN: 2227-9059
Argitalpen urtea: 2023
Alea: 11
Zenbakia: 10
Mota: Artikulua
